{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:46:40Z","timestamp":1787586400605,"version":"build-2736575974"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Schleswig-Holstein - Campus Kiel"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This study aimed to evaluate the effects of a 12-week programme, including moderate strength training with and without whole-body vibration (WBV), on chemotherapy-induced peripheral neuropathy (CIPN) associated symptoms in breast cancer patients undergoing paclitaxel-containing therapy. The goal was to assess the effects on sensory, motor, and autonomic symptoms and on balance, depth sensitivity, and the vibration sensation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this randomized controlled trial, 66 patients were allocated to one of three groups: (i) strength training only (SG), (ii) strength training with WBV (VG), and (iii) a control group (CG) with standard activity advices. Supervised training sessions occurred twice a week during chemotherapy. Outcomes, including balance (Fullerton Advanced Balance Scale, Berg Balance Scale), vibration sensation (tuning fork test), and CIPN symptoms (EORTC QLQ-CIPN20), were assessed at baseline (T0), 6\u00a0weeks (T1), and 12\u00a0weeks (T2).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>No adverse events were recorded, and adherence was high (68.18%). Positive trends indicated stabilized vibration sensation in the SG and VG compared to the control group, but no significant differences were observed. Vibration perception decreased less in the intervention groups, and motor symptoms worsened only in the control group. Balance remained stable across all groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Both strength training alone and combined with WBV are feasible and safe during chemotherapy. Although WBV did not provide additional benefits over strength training alone, both interventions showed potential protective effects against CIPN symptoms.<\/jats:p>\n                    <jats:p>Implications for cancer survivors.<\/jats:p>\n                    <jats:p>Moderate strength training, with or without WBV, may help prevent or alleviate CIPN symptoms, supporting better physical function during chemotherapy. Early implementation of such programmes could reduce treatment-related side effects.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00520-025-09972-y","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T20:57:11Z","timestamp":1760993831000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effects on chemotherapy-induced peripheral neuropathy by moderate strength training in combination with whole-body vibration in breast cancer patients"],"prefix":"10.1007","volume":"33","author":[{"given":"Rebecca","family":"Dalferth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Hebbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Bauerschlag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Letsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,20]]},"reference":[{"key":"9972_CR1","unstructured":"Robert Koch-Institut. Brustkrebs (Mammakarzinom). Available from: https:\/\/www.krebsdaten.de\/Krebs\/DE\/Content\/Krebsarten\/Brustkrebs\/brustkrebs_node.html. Accessed 2 Oct 2025"},{"key":"9972_CR2","unstructured":"Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF (2021) Leitlinienprogramm Onkologie: S3-Leitlinie Fr\u00fcherkennung, Diagnose, Therapie und Nachsorge des Mammakarzinoms, Version 4.4, 2021, AWMF Registernummer: 032\u2013045OL. Available from: http:\/\/www.leitlinienprogramm-onkologie.de\/leitlinien\/mammakarzinom\/. Accessed 22 Feb 2022"},{"issue":"18","key":"9972_CR3","first-page":"316","volume":"115","author":"A W\u00f6ckel","year":"2018","unstructured":"W\u00f6ckel A et al (2018) The screening, diagnosis, treatment, and follow-up of breast cancer. Dtsch Arztebl Int 115(18):316\u2013323","journal-title":"Dtsch Arztebl Int"},{"issue":"6","key":"9972_CR4","first-page":"419","volume":"63","author":"SB Park","year":"2013","unstructured":"Park SB et al (2013) Chemotherapy-induced peripheral neurotoxicity: a critical analysis. CA Cancer J Clin 63(6):419\u2013437","journal-title":"CA Cancer J Clin"},{"key":"9972_CR5","unstructured":"Deutsche Krebsgesellschaft, Deutsche Krebshilfe, and AWMF. Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): Supportive Therapie bei onkologischen PatientInnen - Langversion 1.3, AWMF Registernummer: 032\/054OL,. 2020 [cited 2022 February 22]; Available from: https:\/\/www.leitlinienprogramm-onkologie.de\/leitlinien\/supportive-therapie\/"},{"key":"9972_CR6","unstructured":"U.S. Department of Health and Human Services. Common terminology criteria for adverse events (CTCAE), Version 5.0 (2017) Available from: https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm#ctc_60. Accessed 23 Apr 2025"},{"issue":"3","key":"9972_CR7","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s10549-010-1278-0","volume":"125","author":"DL Hershman","year":"2011","unstructured":"Hershman DL et al (2011) Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy. Breast Cancer Res Treat 125(3):767\u2013774","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"9972_CR8","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/onco.13697","volume":"26","author":"HC Timmins","year":"2021","unstructured":"Timmins HC et al (2021) Weekly paclitaxel-induced neurotoxicity in breast cancer: outcomes and dose response. Oncologist 26(5):366\u2013374","journal-title":"Oncologist"},{"issue":"3","key":"9972_CR9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/mus.21874","volume":"43","author":"SB Park","year":"2011","unstructured":"Park SB et al (2011) Early, progressive, and sustained dysfunction of sensory axons underlies paclitaxel-induced neuropathy. Muscle Nerve 43(3):367\u2013374","journal-title":"Muscle Nerve"},{"issue":"8","key":"9972_CR10","first-page":"4223","volume":"29","author":"C Maih\u00f6fner","year":"2021","unstructured":"Maih\u00f6fner C et al (2021) Chemotherapy-induced peripheral neuropathy (CIPN): current therapies and topical treatment option with high-concentration capsaicin. Support Care Cancer 29(8):4223\u20134238","journal-title":"Support Care Cancer"},{"issue":"2","key":"9972_CR11","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10549-017-4437-8","volume":"166","author":"M Mustafa Ali","year":"2017","unstructured":"Mustafa Ali M et al (2017) Long-term peripheral neuropathy symptoms in breast cancer survivors. Breast Cancer Res Treat 166(2):519\u2013526","journal-title":"Breast Cancer Res Treat"},{"issue":"23","key":"9972_CR12","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1200\/JCO.2016.71.3552","volume":"35","author":"KM Winters-Stone","year":"2017","unstructured":"Winters-Stone KM et al (2017) Falls, functioning, and disability among women with persistent symptoms of chemotherapy-induced peripheral neuropathy. J Clin Oncol 35(23):2604\u20132612","journal-title":"J Clin Oncol"},{"issue":"3","key":"9972_CR13","first-page":"583","volume":"20","author":"C Tofthagen","year":"2012","unstructured":"Tofthagen C, Overcash J, Kip K (2012) Falls in persons with chemotherapy-induced peripheral neuropathy. Support Care Cancer 20(3):583\u2013589","journal-title":"Support Care Cancer"},{"issue":"7","key":"9972_CR14","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1001\/jamaneurol.2016.0383","volume":"73","author":"NA Kolb","year":"2016","unstructured":"Kolb NA et al (2016) The association of chemotherapy-induced peripheral neuropathy symptoms and the risk of falling. JAMA Neurol 73(7):860\u2013866","journal-title":"JAMA Neurol"},{"issue":"3","key":"9972_CR15","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s10549-020-06079-2","volume":"186","author":"WI Zhi","year":"2021","unstructured":"Zhi WI et al (2021) Characterization of chemotherapy-induced peripheral neuropathy using patient-reported outcomes and quantitative sensory testing. Breast Cancer Res Treat 186(3):761\u2013768","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"9972_CR16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/PL00007853","volume":"249","author":"S Quasthoff","year":"2002","unstructured":"Quasthoff S, Hartung HP (2002) Chemotherapy-induced peripheral neuropathy. J Neurol 249(1):9\u201317","journal-title":"J Neurol"},{"key":"9972_CR17","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00086","volume":"8","author":"N Kerckhove","year":"2017","unstructured":"Kerckhove N et al (2017) Long-term effects, pathophysiological mechanisms, and risk factors of chemotherapy-induced peripheral neuropathies: a comprehensive literature review. Front Pharmacol 8:86","journal-title":"Front Pharmacol"},{"issue":"5","key":"9972_CR18","doi-asserted-by":"crossref","first-page":"e234","DOI":"10.1200\/JOP.2012.000863","volume":"9","author":"RM Speck","year":"2013","unstructured":"Speck RM et al (2013) Impact of chemotherapy-induced peripheral neuropathy on treatment delivery in nonmetastatic breast cancer. J Oncol Pract 9(5):e234\u2013e240","journal-title":"J Oncol Pract"},{"issue":"6","key":"9972_CR19","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ana.24951","volume":"81","author":"NP Staff","year":"2017","unstructured":"Staff NP et al (2017) Chemotherapy-induced peripheral neuropathy: a current review. Ann Neurol 81(6):772\u2013781","journal-title":"Ann Neurol"},{"key":"9972_CR20","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.6004\/jnccn.2009.0078","volume":"7 Suppl 5","author":"MD Stubblefield","year":"2009","unstructured":"Stubblefield MD et al (2009) NCCN task force report: management of neuropathy in cancer. J Natl Compr Canc Netw 7 Suppl 5:S1\u2013S26 (quiz S27-8)","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"9972_CR21","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s40487-021-00168-y","volume":"9","author":"J Burgess","year":"2021","unstructured":"Burgess J et al (2021) Chemotherapy-induced peripheral neuropathy: epidemiology, pathomechanisms and treatment. Oncol Ther 9(2):385\u2013450","journal-title":"Oncol Ther"},{"key":"9972_CR22","doi-asserted-by":"crossref","unstructured":"Budman DR et al (1998) Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B. J Natl Cancer Inst 90(16):1205\u201311","DOI":"10.1093\/jnci\/90.16.1205"},{"issue":"18","key":"9972_CR23","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2013.54.0914","volume":"32","author":"DL Hershman","year":"2014","unstructured":"Hershman DL et al (2014) Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American society of clinical oncology clinical practice guideline. J Clin Oncol 32(18):1941\u20131967","journal-title":"J Clin Oncol"},{"issue":"7","key":"9972_CR24","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1249\/MSS.0b013e3181e0c112","volume":"42","author":"KH Schmitz","year":"2010","unstructured":"Schmitz KH et al (2010) American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42(7):1409\u20131426","journal-title":"Med Sci Sports Exerc"},{"issue":"8","key":"9972_CR25","first-page":"3229","volume":"32","author":"T Schmidt","year":"2012","unstructured":"Schmidt T et al (2012) Gentle strength training in rehabilitation of breast cancer patients compared to conventional therapy. Anticancer Res 32(8):3229\u20133233","journal-title":"Anticancer Res"},{"issue":"9","key":"9972_CR26","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s40279-014-0207-5","volume":"44","author":"F Streckmann","year":"2014","unstructured":"Streckmann F et al (2014) Exercise intervention studies in patients with peripheral neuropathy: a systematic review. Sports Med 44(9):1289\u20131304","journal-title":"Sports Med"},{"issue":"2","key":"9972_CR27","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/annonc\/mdt568","volume":"25","author":"F Streckmann","year":"2014","unstructured":"Streckmann F et al (2014) Exercise program improves therapy-related side-effects and quality of life in lymphoma patients undergoing therapy. Ann Oncol 25(2):493\u2013499","journal-title":"Ann Oncol"},{"key":"9972_CR28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s12156-010-0044-1","volume":"4","author":"sK Wonders","year":"2011","unstructured":"Wonders sK, Reigle B, Drury D (2011) Treatment strategies for chemotherapy-induced peripheral neuropathy: potential role of exercise. Oncol Rev 4:117\u2013125","journal-title":"Oncol Rev"},{"issue":"3","key":"9972_CR29","doi-asserted-by":"crossref","DOI":"10.4081\/hpr.2013.1450","volume":"1","author":"KY Wonders","year":"2013","unstructured":"Wonders KY et al (2013) Ten weeks of home-based exercise attenuates symptoms of chemotherapy-induced peripheral neuropathy in breast cancer patients. Health Psychol Res 1(3):e28","journal-title":"Health Psychol Res"},{"issue":"4","key":"9972_CR30","first-page":"1019","volume":"26","author":"IR Kleckner","year":"2018","unstructured":"Kleckner IR et al (2018) Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial. Support Care Cancer 26(4):1019\u20131028","journal-title":"Support Care Cancer"},{"issue":"5","key":"9972_CR31","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1159\/000442253","volume":"62","author":"M Schwenk","year":"2016","unstructured":"Schwenk M et al (2016) Interactive sensor-based balance training in older cancer patients with chemotherapy-induced peripheral neuropathy: a randomized controlled trial. Gerontology 62(5):553\u2013563","journal-title":"Gerontology"},{"key":"9972_CR32","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40164-017-0065-6","volume":"6","author":"SS Sch\u00f6nsteiner","year":"2017","unstructured":"Sch\u00f6nsteiner SS et al (2017) A randomized exploratory phase 2 study in patients with chemotherapy-related peripheral neuropathy evaluating whole-body vibration training as adjunct to an integrated program including massage, passive mobilization and physical exercises. Exp Hematol Oncol 6:5","journal-title":"Exp Hematol Oncol"},{"issue":"7","key":"9972_CR33","first-page":"2471","volume":"27","author":"F Streckmann","year":"2019","unstructured":"Streckmann F et al (2019) Sensorimotor training and whole-body vibration training have the potential to reduce motor and sensory symptoms of chemotherapy-induced peripheral neuropathy-a randomized controlled pilot trial. Support Care Cancer 27(7):2471\u20132478","journal-title":"Support Care Cancer"},{"issue":"1","key":"9972_CR34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2302\/kjm.56.28","volume":"56","author":"K Kawanabe","year":"2007","unstructured":"Kawanabe K et al (2007) Effect of whole-body vibration exercise and muscle strengthening, balance, and walking exercises on walking ability in the elderly. Keio J Med 56(1):28\u201333","journal-title":"Keio J Med"},{"issue":"5","key":"9972_CR35","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00421-009-1303-3","volume":"108","author":"J Rittweger","year":"2010","unstructured":"Rittweger J (2010) Vibration as an exercise modality: how it may work, and what its potential might be. Eur J Appl Physiol 108(5):877\u2013904","journal-title":"Eur J Appl Physiol"},{"issue":"4","key":"9972_CR36","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1620\/tjem.231.305","volume":"231","author":"K Lee","year":"2013","unstructured":"Lee K, Lee S, Song C (2013) Whole-body vibration training improves balance, muscle strength and glycosylated hemoglobin in elderly patients with diabetic neuropathy. Tohoku J Exp Med 231(4):305\u2013314","journal-title":"Tohoku J Exp Med"},{"issue":"1","key":"9972_CR37","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s40200-019-00476-1","volume":"19","author":"A Jamal","year":"2020","unstructured":"Jamal A et al (2020) Whole body vibration showed beneficial effect on pain, balance measures and quality of life in painful diabetic peripheral neuropathy: a randomized controlled trial. J Diabetes Metab Disord 19(1):61\u201369","journal-title":"J Diabetes Metab Disord"},{"issue":"9","key":"9972_CR38","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1589\/jpts.29.1684","volume":"29","author":"K Lee","year":"2017","unstructured":"Lee K (2017) Effects of whole-body vibration therapy on perception thresholds of type 2 diabetic patients with peripheral neuropathy: a randomized controlled trial. J Phys Ther Sci 29(9):1684\u20131688","journal-title":"J Phys Ther Sci"},{"issue":"2","key":"9972_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jbmt.2020.01.004","volume":"24","author":"NJ Kessler","year":"2020","unstructured":"Kessler NJ, Lockard MM, Fischer J (2020) Whole body vibration improves symptoms of diabetic peripheral neuropathy. J Bodyw Mov Ther 24(2):1\u20133","journal-title":"J Bodyw Mov Ther"},{"issue":"4","key":"9972_CR40","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jbmt.2013.03.001","volume":"17","author":"NJ Kessler","year":"2013","unstructured":"Kessler NJ, Hong J (2013) Whole body vibration therapy for painful diabetic peripheral neuropathy: a pilot study. J Bodyw Mov Ther 17(4):518\u2013522","journal-title":"J Bodyw Mov Ther"},{"issue":"6","key":"9972_CR41","first-page":"468","volume":"69","author":"KH Schmitz","year":"2019","unstructured":"Schmitz KH et al (2019) Exercise is medicine in oncology: engaging clinicians to help patients move through cancer. CA Cancer J Clin 69(6):468\u2013484","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"9972_CR42","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1249\/MSS.0000000000002116","volume":"51","author":"KL Campbell","year":"2019","unstructured":"Campbell KL et al (2019) Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable. Med Sci Sports Exerc 51(11):2375\u20132390","journal-title":"Med Sci Sports Exerc"},{"key":"9972_CR43","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c332","volume":"340","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D (2010) CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 340:c332","journal-title":"BMJ"},{"issue":"8","key":"9972_CR44","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.ejca.2005.02.012","volume":"41","author":"TJ Postma","year":"2005","unstructured":"Postma TJ et al (2005) The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. Eur J Cancer 41(8):1135\u20131139","journal-title":"Eur J Cancer"},{"issue":"10","key":"9972_CR45","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1007\/s11136-013-0379-8","volume":"22","author":"EM Lavoie Smith","year":"2013","unstructured":"Lavoie Smith EM et al (2013) Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 questionnaire. Qual Life Res 22(10):2787\u20132799","journal-title":"Qual Life Res"},{"issue":"2","key":"9972_CR46","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/annonc\/mds329","volume":"24","author":"G Cavaletti","year":"2013","unstructured":"Cavaletti G et al (2013) The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings. Ann Oncol 24(2):454\u2013462","journal-title":"Ann Oncol"},{"issue":"11","key":"9972_CR47","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.apmr.2006.07.263","volume":"87","author":"DJ Rose","year":"2006","unstructured":"Rose DJ, Lucchese N, Wiersma LD (2006) Development of a multidimensional balance scale for use with functionally independent older adults. Arch Phys Med Rehabil 87(11):1478\u20131485","journal-title":"Arch Phys Med Rehabil"},{"issue":"12","key":"9972_CR48","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/j.apmr.2008.05.020","volume":"89","author":"D Hernandez","year":"2008","unstructured":"Hernandez D, Rose DJ (2008) Predicting which older adults will or will not fall using the Fullerton Advanced Balance scale. Arch Phys Med Rehabil 89(12):2309\u20132315","journal-title":"Arch Phys Med Rehabil"},{"key":"9972_CR49","doi-asserted-by":"crossref","unstructured":"Berg K et al (1989) Measuring balance in the elderly: preliminary development of an instrument. Physiotherapy Canada 41(6):304\u2013311","DOI":"10.3138\/ptc.41.6.304"},{"issue":"Suppl 2","key":"9972_CR50","first-page":"S7","volume":"83","author":"KO Berg","year":"1992","unstructured":"Berg KO et al (1992) Measuring balance in the elderly: validation of an instrument. Can J Public Health 83(Suppl 2):S7-11","journal-title":"Can J Public Health"},{"issue":"4","key":"9972_CR51","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1055\/s-2002-36763","volume":"22","author":"DJ Lanska","year":"2002","unstructured":"Lanska DJ (2002) The Romberg sign and early instruments for measuring postural sway. Semin Neurol 22(4):409\u2013418","journal-title":"Semin Neurol"},{"issue":"5","key":"9972_CR52","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/jnnp.65.5.743","volume":"65","author":"IS Martina","year":"1998","unstructured":"Martina IS et al (1998) Measuring vibration threshold with a graduated tuning fork in normal aging and in patients with polyneuropathy. European Inflammatory Neuropathy Cause and Treatment (INCAT) group. J Neurol Neurosurg Psychiatry 65(5):743\u2013747","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"9972_CR53","first-page":"2767","volume":"22","author":"DA da Silva Sim\u00e3o","year":"2014","unstructured":"da Silva Sim\u00e3o DA et al (2014) Evaluation of the Semmes-Weinstein filaments and a questionnaire to assess chemotherapy-induced peripheral neuropathy. Support Care Cancer 22(10):2767\u20132773","journal-title":"Support Care Cancer"},{"issue":"9","key":"9972_CR54","first-page":"5303","volume":"29","author":"WL Lin","year":"2021","unstructured":"Lin WL et al (2021) The effects of exercise on chemotherapy-induced peripheral neuropathy symptoms in cancer patients: a systematic review and meta-analysis. Support Care Cancer 29(9):5303\u20135311","journal-title":"Support Care Cancer"},{"issue":"3","key":"9972_CR55","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/1545968319899918","volume":"34","author":"E Andersen Hammond","year":"2020","unstructured":"Andersen Hammond E et al (2020) An exploratory randomized trial of physical therapy for the treatment of chemotherapy-induced peripheral neuropathy. Neurorehabil Neural Repair 34(3):235\u2013246","journal-title":"Neurorehabil Neural Repair"},{"issue":"4","key":"9972_CR56","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/NCC.0000000000000693","volume":"43","author":"S Dhawan","year":"2020","unstructured":"Dhawan S et al (2020) A randomized controlled trial to assess the effectiveness of muscle strengthening and balancing exercises on chemotherapy-induced peripheral neuropathic pain and quality of life among cancer patients. Cancer Nurs 43(4):269\u2013280","journal-title":"Cancer Nurs"},{"issue":"10","key":"9972_CR57","first-page":"3849","volume":"27","author":"JM McCrary","year":"2019","unstructured":"McCrary JM et al (2019) Exercise-based rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy. Support Care Cancer 27(10):3849\u20133857","journal-title":"Support Care Cancer"},{"issue":"1","key":"9972_CR58","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ygyno.2015.11.011","volume":"140","author":"JR Brewer","year":"2016","unstructured":"Brewer JR et al (2016) Chemotherapy-induced peripheral neuropathy: current status and progress. Gynecol Oncol 140(1):176\u2013183","journal-title":"Gynecol Oncol"},{"key":"9972_CR59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diabres.2019.03.029","volume":"151","author":"MT Olaiya","year":"2019","unstructured":"Olaiya MT et al (2019) Use of graded Semmes Weinstein monofilament testing for ascertaining peripheral neuropathy in people with and without diabetes. Diabetes Res Clin Pract 151:1\u201310","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"9972_CR60","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1757-1146-1-9","volume":"1","author":"MP Thomson","year":"2008","unstructured":"Thomson MP et al (2008) Threshold for detection of diabetic peripheral sensory neuropathy using a range of research grade monofilaments in persons with type 2 diabetes mellitus. J Foot Ankle Res 1(1):9","journal-title":"J Foot Ankle Res"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09972-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-09972-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09972-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T13:03:33Z","timestamp":1763211813000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-09972-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,20]]},"references-count":60,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["9972"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-09972-y","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,20]]},"assertion":[{"value":"10 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The study was approved by the Ethics Committee of the Faculty of Medicine at Christian-Albrechts-University Kiel in November 2018 (reference number: D556\/18).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"970"}}